Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 165

1.

Tumorigenic and metastatic activity of human thyroid cancer stem cells.

Todaro M, Iovino F, Eterno V, Cammareri P, Gambara G, Espina V, Gulotta G, Dieli F, Giordano S, De Maria R, Stassi G.

Cancer Res. 2010 Nov 1;70(21):8874-85. doi: 10.1158/0008-5472.CAN-10-1994. Epub 2010 Oct 19.

2.

Epstein-Barr virus-encoded LMP2A induces an epithelial-mesenchymal transition and increases the number of side population stem-like cancer cells in nasopharyngeal carcinoma.

Kong QL, Hu LJ, Cao JY, Huang YJ, Xu LH, Liang Y, Xiong D, Guan S, Guo BH, Mai HQ, Chen QY, Zhang X, Li MZ, Shao JY, Qian CN, Xia YF, Song LB, Zeng YX, Zeng MS.

PLoS Pathog. 2010 Jun 3;6(6):e1000940. doi: 10.1371/journal.ppat.1000940.

3.

Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis.

Marcato P, Dean CA, Pan D, Araslanova R, Gillis M, Joshi M, Helyer L, Pan L, Leidal A, Gujar S, Giacomantonio CA, Lee PW.

Stem Cells. 2011 Jan;29(1):32-45. doi: 10.1002/stem.563.

4.

Expression of telomerase genes in thyroid carcinoma.

Hoang-Vu C, Boltze C, Gimm O, Poremba C, Dockhorn-Dworniczak B, Köhrle J, Rath FW, Dralle H.

Int J Oncol. 2002 Aug;21(2):265-72. Review.

PMID:
12118320
5.
6.

A CD90(+) tumor-initiating cell population with an aggressive signature and metastatic capacity in esophageal cancer.

Tang KH, Dai YD, Tong M, Chan YP, Kwan PS, Fu L, Qin YR, Tsao SW, Lung HL, Lung ML, Tong DK, Law S, Chan KW, Ma S, Guan XY.

Cancer Res. 2013 Apr 1;73(7):2322-32. doi: 10.1158/0008-5472.CAN-12-2991. Epub 2013 Feb 4.

7.

ALDH high adenoid cystic carcinoma cells display cancer stem cell properties and are responsible for mediating metastasis.

Sun S, Wang Z.

Biochem Biophys Res Commun. 2010 Jun 11;396(4):843-8. doi: 10.1016/j.bbrc.2010.04.170. Epub 2010 May 5.

PMID:
20450887
8.

Tumorigenic role of podoplanin in esophageal squamous-cell carcinoma.

Rahadiani N, Ikeda J, Makino T, Tian T, Qiu Y, Mamat S, Wang Y, Doki Y, Aozasa K, Morii E.

Ann Surg Oncol. 2010 May;17(5):1311-23. doi: 10.1245/s10434-009-0895-5. Epub 2010 Jan 12.

PMID:
20066519
9.

Effect of {beta}4 integrin knockdown by RNA interference in anaplastic thyroid carcinoma.

Noh TW, Soung YH, Kim HI, Gil HJ, Kim JM, Lee EJ, Chung J.

Anticancer Res. 2010 Nov;30(11):4485-92.

PMID:
21115897
10.

Essential role of aldehyde dehydrogenase 1A3 for the maintenance of non-small cell lung cancer stem cells is associated with the STAT3 pathway.

Shao C, Sullivan JP, Girard L, Augustyn A, Yenerall P, Rodriguez-Canales J, Liu H, Behrens C, Shay JW, Wistuba II, Minna JD.

Clin Cancer Res. 2014 Aug 1;20(15):4154-66. doi: 10.1158/1078-0432.CCR-13-3292. Epub 2014 Jun 6.

11.

Development of a highly metastatic model that reveals a crucial role of fibronectin in lung cancer cell migration and invasion.

Jia D, Yan M, Wang X, Hao X, Liang L, Liu L, Kong H, He X, Li J, Yao M.

BMC Cancer. 2010 Jul 9;10:364. doi: 10.1186/1471-2407-10-364.

12.

Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation.

Shi X, Jin Y, Cheng C, Zhang H, Zou W, Zheng Q, Lu Z, Chen Q, Lai Y, Pan J.

Clin Cancer Res. 2009 Mar 1;15(5):1686-97. doi: 10.1158/1078-0432.CCR-08-2141. Epub 2009 Feb 24.

13.

Lin-28B expression promotes transformation and invasion in human hepatocellular carcinoma.

Wang YC, Chen YL, Yuan RH, Pan HW, Yang WC, Hsu HC, Jeng YM.

Carcinogenesis. 2010 Sep;31(9):1516-22. doi: 10.1093/carcin/bgq107. Epub 2010 Jun 4.

PMID:
20525879
14.

Ca2+/calmodulin-dependent protein kinase IIγ enhances stem-like traits and tumorigenicity of lung cancer cells.

Chai S, Xu X, Wang Y, Zhou Y, Zhang C, Yang Y, Yang Y, Xu H, Xu R, Wang K.

Oncotarget. 2015 Jun 30;6(18):16069-83.

15.

Overexpression and overactivation of Akt in thyroid carcinoma.

Ringel MD, Hayre N, Saito J, Saunier B, Schuppert F, Burch H, Bernet V, Burman KD, Kohn LD, Saji M.

Cancer Res. 2001 Aug 15;61(16):6105-11.

16.

The properties of tumor-initiating cells from a hepatocellular carcinoma patient's primary and recurrent tumor.

Xu XL, Xing BC, Han HB, Zhao W, Hu MH, Xu ZL, Li JY, Xie Y, Gu J, Wang Y, Zhang ZQ.

Carcinogenesis. 2010 Feb;31(2):167-74. doi: 10.1093/carcin/bgp232. Epub 2009 Nov 6.

PMID:
19897602
17.

Human telomerase reverse transcriptase (hTERT) gene expression in FNA samples from thyroid neoplasms.

Liou MJ, Chan EC, Lin JD, Liu FH, Chao TC.

Cancer Lett. 2003 Mar 10;191(2):223-7.

PMID:
12618337
18.

Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer.

Chang XZ, Li DQ, Hou YF, Wu J, Lu JS, Di GH, Jin W, Ou ZL, Shen ZZ, Shao ZM.

Breast Cancer Res. 2007;9(6):R76.

19.

CEACAM1 impedes thyroid cancer growth but promotes invasiveness: a putative mechanism for early metastases.

Liu W, Wei W, Winer D, Bamberger AM, Bamberger C, Wagener C, Ezzat S, Asa SL.

Oncogene. 2007 Apr 26;26(19):2747-58. Epub 2006 Oct 23.

PMID:
17057731
20.

ALDH activity indicates increased tumorigenic cells, but not cancer stem cells, in prostate cancer cell lines.

Yu C, Yao Z, Dai J, Zhang H, Escara-Wilke J, Zhang X, Keller ET.

In Vivo. 2011 Jan-Feb;25(1):69-76.

PMID:
21282737

Supplemental Content

Support Center